212 related articles for article (PubMed ID: 25924010)
21. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
[TBL] [Abstract][Full Text] [Related]
22. Post-renal transplant hemolytic uremic syndrome following combination therapy with tacrolimus and everolimus.
Pratap B; Abraham G; Srinivas CN; Bhaskar S
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):609-12. PubMed ID: 17951952
[TBL] [Abstract][Full Text] [Related]
23. Conversion to everolimus in a patient with arterial hypertension and recurrent cutaneous neoplasia--a case report.
Pascual J; Fernández AM; Marcén R; Ortuño J
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii38-41. PubMed ID: 16815857
[TBL] [Abstract][Full Text] [Related]
24. Conversion from calcineurin inhibitors to everolimus in kidney transplant recipients with malignant neoplasia.
Fernández A; Marcén R; Pascual J; Galeano C; Ocaña J; Arellano EM; Alfaro C; Villafruela JJ; Burgos FJ; Ortuño J
Transplant Proc; 2006 Oct; 38(8):2453-5. PubMed ID: 17097965
[TBL] [Abstract][Full Text] [Related]
25. Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.
Belliere J; Kamar N; Mengelle C; Allal A; Sallusto F; Doumerc N; Game X; Congy-Jolivet N; Esposito L; Debiol B; Rostaing L
Transpl Int; 2016 Mar; 29(3):315-22. PubMed ID: 26575959
[TBL] [Abstract][Full Text] [Related]
26. Conversion from tacrolimus/mycophenolic acid to tacrolimus/leflunomide to treat cutaneous warts in a series of four pediatric renal allograft recipients.
Nguyen L; McClellan RB; Chaudhuri A; Alexander SR; Chen SF; Concepcion W; Grimm P
Transplantation; 2012 Sep; 94(5):450-5. PubMed ID: 22960763
[TBL] [Abstract][Full Text] [Related]
27. Sebaceous carcinoma in patients receiving long-term immunosuppresive treatment: case report and literature review.
Imko-Walczuk B; Kryś A; Lizakowski S; Dębska-Ślizień A; Rutkowski B; Biernat W; Wojnarowska F
Transplant Proc; 2014 Oct; 46(8):2903-7. PubMed ID: 25380947
[TBL] [Abstract][Full Text] [Related]
28. Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation.
Langer RM; Hené R; Vitko S; Christiaans M; Tedesco-Silva H; Ciechanowski K; Cassuto E; Rostaing L; Vilatoba M; Machein U; Ulbricht B; Junge G; Dong G; Pascual J
Transpl Int; 2012 May; 25(5):592-602. PubMed ID: 22471345
[TBL] [Abstract][Full Text] [Related]
29. Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.
Bilbao I; Salcedo M; Gómez MA; Jimenez C; Castroagudín J; Fabregat J; Almohalla C; Herrero I; Cuervas-Mons V; Otero A; Rubín A; Miras M; Rodrigo J; Serrano T; Crespo G; De la Mata M; Bustamante J; Gonzalez-Dieguez ML; Moreno A; Narvaez I; Guilera M;
Liver Transpl; 2015 Aug; 21(8):1056-65. PubMed ID: 25990257
[TBL] [Abstract][Full Text] [Related]
30. Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus.
de Sandes-Freitas TV; Felipe CR; Campos ÉF; de Lima MG; Soares MF; de Franco MF; Aguiar WF; Tedesco-Silva H; Medina-Pestana JO
Transplantation; 2015 Nov; 99(11):2372-81. PubMed ID: 25929604
[TBL] [Abstract][Full Text] [Related]
31. Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial.
Sommerer C; Suwelack B; Dragun D; Schenker P; Hauser IA; Nashan B; Thaiss F
Trials; 2016 Feb; 17():92. PubMed ID: 26888217
[TBL] [Abstract][Full Text] [Related]
32. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
[TBL] [Abstract][Full Text] [Related]
33. Condyloma Acuminata of the Urethra in a Male Renal Transplant Recipient: A Case Report.
Hamano I; Hatakeyama S; Yamamoto H; Fujita T; Murakami R; Shimada M; Imai A; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Narumi S; Saitoh H; Suzuki T; Tomita H; Ohyama C
Transplant Proc; 2018 Oct; 50(8):2553-2557. PubMed ID: 30316397
[TBL] [Abstract][Full Text] [Related]
34. Rare cause of odynophagia: Giant esophageal ulcer.
Veroux M; Aprile G; Amore FF; Corona D; Giaquinta A; Veroux P
World J Gastroenterol; 2016 Apr; 22(14):3875-8. PubMed ID: 27076774
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
[TBL] [Abstract][Full Text] [Related]
36. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.
Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S
J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients.
Brunkhorst LC; Fichtner A; Höcker B; Burmeister G; Ahlenstiel-Grunow T; Krupka K; Bald M; Zapf A; Tönshoff B; Pape L
PLoS One; 2015; 10(9):e0135439. PubMed ID: 26407177
[TBL] [Abstract][Full Text] [Related]
38. De Novo Malignant Neoplasms in Renal Transplant Patients.
Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Deniz E; Börcek P; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):100-105. PubMed ID: 27805524
[TBL] [Abstract][Full Text] [Related]
39. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
[TBL] [Abstract][Full Text] [Related]
40. Late, severe, noninfectious diarrhea after renal transplantation: high-risk factors, therapy, and prognosis.
Zhao YJ; Wen JQ; Cheng K; Ming YZ; She XG; Liu H; Liu L; Ye QF; Ding BN
Transplant Proc; 2013; 45(6):2226-32. PubMed ID: 23953533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]